Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Jinlong, Shi ^a,b   Lin, Fu ^c   Yonghui, Li ^b   Li, Yu ^b   Weidong, Wang ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LET 7A 2 3P; MICRORNA; MICRORNA 188 5P; UNCLASSIFIED DRUG; MIRN188 MICRORNA, HUMAN; MIRNLET7 MICRORNA, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; EVENT FREE SURVIVAL; FEMALE; FOSB GENE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IGJ GENE; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; RISK FACTOR; RNA SEQUENCE; SNORD50A GENE; UPREGULATION; VERY ELDERLY; ZNF502 GENE; GENE EXPRESSION REGULATION; GENETICS; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; YOUNG ADULT;

EID: 84922363035     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118099     Document Type: Article

References (42)

1. Burnett AK (2002) Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?-an adult treater's view. Br J Haematol 118: 357-364. PMID: 12139719
2. Mrozek K, Marcucci G, Paschka P, Whitman SP, Bloomfield CD (2007) Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood 109: 431-448. PMID: 16960150
3. Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, et al. (2004) Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 350: 1617-1628. PMID: 15084694
4. Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, et al. (2005) Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 352: 254-266. PMID: 15659725
5. Frohling S, Schlenk RF, Stolze I, Bihlmayr J, Benner A, et al. (2004) CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. J Clin Oncol 22: 624-633. PMID: 14726504
6. Kiyoi H, Naoe T, Nakano Y, Yokota S, Minami S, et al. (1999) Prognostic implication of FLT3 and NRAS gene mutations in acute myeloid leukemia. Blood 93: 3074-3080. PMID: 10216104
7. Becker H, Marcucci G, Maharry K, Radmacher MD, Mrozek K, et al. (2010) Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Blood 116: 788-792. doi: 10.1182/blood-2010-01-262543 PMID: 20442368
8. Schwind S, Marcucci G, Maharry K, Radmacher MD, Mrozek K, et al. (2010) BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Blood 116: 5660-5669. doi: 10.1182/blood-2010-06-290536 PMID: 20841507
9. Metzeler KH, Heilmeier B, Edmaier KE, Rawat VP, Dufour A, et al. (2012) High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia. Blood 120: 2118-2126. doi: 10.1182/blood-2012-02-411827 PMID: 22815426
10. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297. PMID: 14744438
11. Alemdehy MF, Erkeland SJ (2012) MicroRNAs: key players of normal and malignant myelopoiesis. Curr Opin Hematol 19: 261-267. doi: 10.1097/MOH.0b013e328353d4e9 PMID: 22504525
12. Vasilatou D, Papageorgiou S, Pappa V, Papageorgiou E, Dervenoulas J (2010) The role of microRNAs in normal and malignant hematopoiesis. Eur J Haematol 84: 1-16. doi: 10.1111/j.1600-0609.2009. 01348.x PMID: 19744129
13. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838. PMID: 15944708
14. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101: 2999-3004. PMID: 14973191
15. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, et al. (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99: 15524-15529. PMID: 12434020
16. Mian YA, Zeleznik-Le NJ (2010) MicroRNAs in leukemias: emerging diagnostic tools and therapeutic targets. Curr Drug Targets 11: 801-811. PMID: 20370647
17. Schotte D, Pieters R, Den Boer ML (2012) MicroRNAs in acute leukemia: from biological players to clinical contributors. Leukemia 26: 1-12. doi: 10.1038/leu.2011.151 PMID: 21701489
18. Cancer Genome Atlas Research N (2013) Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 368: 2059-2074. doi: 10.1056/NEJMoa1301689 PMID: 23634996
19. Preudhomme C, Sagot C, Boissel N, Cayuela JM, Tigaud I, et al. (2002) Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA). Blood 100: 2717-2723. PMID: 12351377
20. Khanim FL, Bradbury CA, Arrazi J, Hayden RE, Rye A, et al. (2009) Elevated FOSB-expression; a potential marker of valproate sensitivity in AML. Br J Haematol 144: 332-341. doi: 10.1111/j.1365-2141. 2008.07449.x PMID: 19036090
21. Tan M, Luo H, Lee S, Jin F, Yang JS, et al. (2011) Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 146: 1016-1028. doi: 10.1016/j.cell.2011.08. 008 PMID: 21925322
22. McLaughlin SK, Olsen SN, Dake B, De Raedt T, Lim E, et al. (2013) The RasGAP gene, RASAL2, is a tumor and metastasis suppressor. Cancer Cell 24: 365-378. doi: 10.1016/j.ccr.2013.08.004 PMID: 24029233
23. van der Weyden L, Rust AG, McIntyre RE, Robles-Espinoza CD, del Castillo Velasco-Herrera M, et al. (2013) Jdp2 downregulates Trp53 transcription to promote leukaemogenesis in the context of Trp53 heterozygosity. Oncogene 32: 397-402. doi: 10.1038/onc.2012.56 PMID: 22370638
24. Zheng YS, Zhang H, Zhang XJ, Feng DD, Luo XQ, et al. (2012) MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia. Oncogene 31: 80-92. doi: 10.1038/onc.2011.208 PMID: 21643017
25. Marcucci G, Radmacher MD, Maharry K, Mrozek K, Ruppert AS, et al. (2008) MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 358: 1919-1928. doi: 10.1056/NEJMoa074256 PMID: 18450603
26. Mariathasan S, Monack DM (2007) Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 7: 31-40. PMID: 17186029
27. Schwind S, Maharry K, Radmacher MD, Mrozek K, Holland KB, et al. (2010) Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. J Clin Oncol 28: 5257-5264. doi: 10.1200/JCO.2010.29.2953 PMID: 21079133
28. Landais S, Landry S, Legault P, Rassart E (2007) Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 67: 5699-5707. PMID: 17575136
29. Tang W, Jiang Y, Mu X, Xu L, Cheng W, et al. (2014) MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression. Cell Signal 26: 1420-1426. doi: 10.1016/j. cellsig.2014.03.002 PMID: 24607788
30. Navarro A, Diaz T, Martinez A, Gaya A, Pons A, et al. (2009) Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. Blood 114: 2945-2951. doi: 10.1182/blood-2009-02-204842 PMID: 19666866
31. Gao L, Yang Y, Xu H, Liu R, Li D, et al. (2014) miR-335 functions as a tumor suppressor in pancreatic cancer by targeting OCT4. Tumour Biol. PMID: 25549795
32. Qiu T, Zhou X, Wang J, Du Y, Xu J, et al. (2014) MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer. FEBS Lett 588: 1168-1177. doi: 10.1016/j.febslet.2014.02.054 PMID: 24613927
33. Song SJ, Ito K, Ala U, Kats L, Webster K, et al. (2013) The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell 13: 87-101. doi: 10.1016/j.stem.2013.06.003 PMID: 23827711
34. Marcucci G, Mrozek K, Radmacher MD, Garzon R, Bloomfield CD (2011) The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood 117: 1121-1129. doi: 10.1182/blood-2010-09-191312 PMID: 21045193
35. Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, et al. (2008) MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111: 3183-3189. doi: 10.1182/blood-2007-07-098749 PMID: 18187662
36. Emmrich S, Katsman-Kuipers JE, Henke K, Khatib ME, Jammal R, et al. (2014)miR-9 is a tumor suppressor in pediatric AML with t(8;21). Leukemia 28: 1022-1032. doi: 10.1038/leu.2013.357 PMID: 24270738
37. Garzon R, Heaphy CE, Havelange V, Fabbri M, Volinia S, et al. (2009) MicroRNA 29b functions in acute myeloid leukemia. Blood 114: 5331-5341. doi: 10.1182/blood-2009-03-211938 PMID: 19850741
38. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198. PMID: 16530703
39. Sirotkin AV, Laukova M, Ovcharenko D, Brenaut P, Mlyncek M (2010) Identification of microRNAs controlling human ovarian cell proliferation and apoptosis. J Cell Physiol 223: 49-56. doi: 10.1002/jcp. 21999 PMID: 20039279
40. Aravind S, Pablo T, Vamsi KM, Sayan M, Benjamin LE, et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550. PMID: 16199517
41. Lee HJ, Daver N, Kantarjian HM, Verstovsek S, Ravandi F (2013) The role of JAK pathway dysregulation in the pathogenesis and treatment of acute myeloid leukemia. Clin Cancer Res 19: 327-335. doi: 10.1158/1078-0432.CCR-12-2087 PMID: 23209034
42. Ufkin ML, Peterson S, Yang X, Driscoll H, Duarte C, et al. (2014) miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia. Leuk Res 38: 402-410. doi: 10.1016/j.leukres.2013.12.021 PMID: 24484870